KRAS and colonic neoplasm: We have previously demonstrated that miRNA-143, which also reduces KRAS expression, chemosensitizes colon cancer cells to 5-fluorouracil [7], and reduces tumor growth in vivo, with increased apoptosis and reduced proliferation [8].